Find a Doctor

Doctor's Name:

Department:

treatment:

Get Consultation

By submitting this form you agree to have your information used for consultation purposes only in accordance with our Privacy Policy.

CAR-T: Promising Treatment for Leukemia at Sheba Medical Center

Leukemia, sometimes called “cancer of the blood,” is the most common malignancy among children. The symptoms of the disease can be devastating, and it is not uncommon for conventional therapies, like chemotherapy and radiation, to fail. Fortunately, efforts to find new and effective treatment options continue daily. One such novel treatment is now offered at Sheba Medical Center: CAR-T.

What is CAR-T

Why Choose Sheba?

Get Consultation Now

We are here to help

By submitting this form you agree to have your information used for consultation purposes only in accordance with our Privacy Policy.

Please leave this field empty.

How Does CAR-T Therapy Work?

CAR-T treatment for leukemia is an innovative process that uses your own immune cells to seek and destroy cancerous cells.

After some blood is taken from the patient, the T-cells, a type of immune cell, are removed from the sample. Using advanced genetic engineering techniques, the T-cells are modified, causing them to create chimeric antigen receptors (CARs). These CARs program the T-cells to find and destroy cancer cells when injected back into the patient.

The patient receives chemotherapy while the modified T-cells grow in our laboratory. The chemotherapy dampens the patient’s immune system, permitting the CAR T-cells to do a better job of eliminating malignant cells.

Who Can Have CAR-T Treatment?

Potential patients need to have undergone at least two prior leukemia treatments. The CAR-T protocol requires hospitalization of at least two weeks, but same patients may need a longer observation period.

Great success has been achieved in young patients with CAR-T treatment. The following are the rates of complete recovery with this therapy:

85-90% in young children
Approximately 80% in teenagers
Around 70% of the entire patient population

Of course, Sheba continues to strive to further improve these rates through continuous research and retaining the best physicians.

If you have a loved one suffering from leukemia, contact us right away. We’ll be happy to answer all your questions and help in every possible way.

Get Consultation about CAR-T Treatment

Sheba – Ranked in the

Top Ten Best Hospitals Worldwide

Sheba Medical Center sets the standard for excellence in patient-focused care. Recently, Newsweek included Sheba on their prestigious list of the Top Ten Best Hospitals Worldwide. This endorsement recognizes Sheba as a leading force in medical science and biotechnological innovation – maximizing the latest technologies while always providing holistic, outstanding healthcare. Sheba is strongly committed to delivering personalized, expert medicine to everyone from all over the world.

The 10 Best Hospitals in the World

Why Come to Sheba for CAR-T Therapy?

There are only a handful of medical facilities in the world that provide CAR-T therapy. There are many benefits to selecting Sheba Medical Center for your treatment, which include:

Sheba is fully accredited by the Joint Commission International (JCI), the recognized authority for international healthcare accreditation
Sheba physicians are top-tier specialists, with many having trained in the US. In fact, Sheba enjoys a close partnership with MD Anderson Cancer Center in Texas
Even though Sheba patients always receive the highest caliber of care, healthcare costs are usually much more affordable in Israel compared to the US
We provide complete CAR-T therapy on site at Sheba. This means you receive all of your treatment under one roof. We even have our own advanced laboratory where T-cells are engineered
We help you every step of the way when you travel to Sheba for treatment. This includes arranging accommodations and providing you with an interpreter. Due to the close relationship between Israel and the US, we can even help Americans obtain on-arrival visas